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Background: In South Africa, HIV/AIDS remains a major public health problem. In a context of chronic unemployment
and deepening poverty, social assistance through a Disability Grant (DG) is extended to adults with HIV/AIDS who are
unable to work because of a mental or physical disability. Using a mixed methods approach, we consider 1) inequalities
in access to the DG for patients on ART and 2) implications of DG access for on-going access to healthcare.
Methods: Data were collected in exit interviews with 1200 ART patients in two rural and two urban health sub-districts in
four different South African provinces. Additionally, 17 and 18 in-depth interviews were completed with patients on ART
treatment and ART providers, respectively, in three of the four sites included in the quantitative phase.
Results: Grant recipients were comparatively worse off than non-recipients in terms of employment (9.1 % vs. 29.9 %)
and wealth (58.3 % in the poorest half vs. 45.8 %). After controlling for socioeconomic and demographic factors, site,
treatment duration, adherence and concomitant TB treatment, the regression analyses showed that the employed were
significantly less likely to receive the DG than the unemployed (p < 0.001). Also, patients who were longer on treatment
and receiving concomitant treatment (i.e., ART and tuberculosis care) were more likely to receive the DG (significant at
the 5 % level). The qualitative analyses indicated that the DG alleviated the burden of healthcare related costs for ART
patients. Both patients and healthcare providers spoke of the complexity of the grants process and eligibility criteria as a
barrier to accessing the grant. This impacted adversely on patient-provider relationships.
Conclusions: These findings highlight the appropriateness of the DG for people living with HIV/AIDS. However, improved
collaboration between the Departments of Social Development and Health is essential for preparing healthcare providers
who are at the interface between social security and potential recipients.
Key words: HIV/AIDS, Healthcare access, Disability grant, South AfricaBackground
“Everyone has the right to have access to health care
services (…) and social security, including, if they are
unable to support themselves and their dependants,
appropriate social assistance.” (Section 27 of the Bill of
Rights, South Africa) [1]
In South Africa (SA), HIV/AIDS remains a major public
health problem. In 2010, approximately 5.5 million were
infected with HIV, making it globally the country with the
largest number of people living with the disease [2]. In a
context of chronic unemployment and deepening poverty,* Correspondence: veloshnee.govender@uct.ac.za
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ameliorate the additional socio-economic burden and
costs of healthcare arising from HIV/AIDS for affected in-
dividuals. First, the provision of free primary health care
has improved access to healthcare. In tackling the HIV
epidemic, approximately 1.4 million people or three quar-
ters of the eligible adults received free antiretroviral treat-
ment (ART) by 2012 [2], making it the largest public ART
programme in the world. Second, the existing social secur-
ity system has been significantly expanded to reach a lar-
ger part of the population, specifically aimed at redressing
past inequities arising from the apartheid system [3]. Here,
the constitutional right to social security is of great rele-
vance, with social security being “an important safety net
that helps relieve poverty and protects people against eco-
nomic shocks” [4]. Social assistance is also extended tos article distributed under the terms of the Creative Commons Attribution
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a mental or physical disability and are deemed eligible to
receive a Disability Grant (DG). Approximately 16.0 million
social grant payments were made to vulnerable people in
January 2013, of which approximately 1.2 million were paid
out as DGs [5].
Eligibility to the DG is defined by the South African So-
cial Security Agency’s (SASSA’s) guidelines [6]. Criteria for
qualification include applicant’s status (i.e., citizen, perman-
ent resident or refugee); being of working age (18 years and
older); passing a means test and having received a medical
assessment report. The disability is assessed and confirmed
by a medical assessor, who is a state appointed doctor. The
DG can be either permanent (for disabilities lasting longer
than 12 months) or temporary (for disabilities between six
and 12 months) and HIV patients are eligible for the
temporary DG. The DG is re-assessed and the person is re-
examined by a doctor every six-months to confirm whether
they still qualify. Hence, ART patients lose their DG as
soon as their health begins to improve.
It has been argued that eligibility to the DG and in par-
ticular the relative vagueness of definitions of ‘people with
disability’ for people with HIV/AIDS has provided a gap for
subjective interpretations for both applicants and the health-
care providers including doctors appointed as medical asses-
sors [7, 8]. Although there are some key principles that
should guide disability assessments, previous research indi-
cates that the medical assessment report which is necessary
to confirm disability is complex, particularly in relation to
eligibility for the temporary and permanent DG [9–12].
Moreover, the on-going challenge of human resource cap-
acity in the public health care sector, particularly the short-
age of doctors, means that few staff are available to assess
disability in public facilities, leaving very little time (as little
as 3 min) to assess a patient’s disability [8].
McIntyre et al. [13] present a conceptual framework
in which access to care is represented by the degree of
fit between the characteristics and contexts of individ-
uals with health care needs and the way the service is
provided. The framework identifies three separate
dimensions of access; affordability (do the individuals
have the capacity to incur the full costs of receiving
care?), availability (is the appropriate care supplied?)
and acceptability (is care supplied in a way that meets
the reasonable expectations of patients?). Both Cleary
et al. [14] and Fried et al. [15] argue that although ART
treatment is provided free of cost at facilities in the
public sector, some patients are still facing financial
challenges in accessing care.
Building on the findings of Cleary et al. [14] and informed
by the access-framework of McIntyre et al. [13], this paper
assesses predictors of access to the DG and how receiving a
DG improves affordability to transport and food which may
in turn impact on other access barriers such as availabilityand acceptability of services. We aim to investigate the
interaction between access to the DG and access to care for
HIV/AIDS. More specifically, we are guided by the follow-
ing two research questions. Are there any inequalities in
access to the DG for patients on ART? What are the impli-
cations of DG access for on-going access to healthcare? In
relation to the access-framework, variations in ability to
meet the shadow price of health care (i.e., the non-
treatments costs associated with access to care) are ex-
pected to be associated with variations in service utilisation.
DGs are considered a means of empowering those with
limited means to meet the costs of accessing care.
We use data from patient-exit interviews across two
urban and two rural sites in SA to investigate presence
of inequalities in access to the DG. We were interested
in the socio-economic, physical location and treatment
characteristics of DG recipients (compared to non-grant
recipients). Relevant is also the healthcare delivery sys-
tem in which the patients’ access to care has an influ-
ence on DG uptake; some facilities may be structured to
promote, encourage and provide support and informa-
tion to patients regarding their social rights including
application for DGs. In addition, some sites are more
urban than others and the composition of socio-economic
backgrounds of patients is likely to vary by site.
We explore underlying factors which either facilitate
or inhibit access to the DG and how these differences in
access play out in terms of healthcare access through
patients’ narratives (both grant and non-grant recipi-
ents) and healthcare providers’ narratives. Uptake of the
DG might be determined by patients’ knowledge and
perceptions about the existence, eligibility conditions
and the DG application process. Previous research indi-
cates that access to information and knowledge about
where to access care or services empowers an individual
[13, 15–17]. We also consider healthcare providers’
knowledge about DGs and their ability to assist patients
in accessing DGs and the implications for the accept-
ability of care.
Methods
The study design was sequential mixed methods, using
both quantitative and qualitative data collection tech-
niques. Methodologically, this approach provides the
opportunity to triangulate objective, quantifiable data
with subjective, experiential data. The quantitative study
(QUAN) employed patient exit interviews using a self-
administered structured questionnaire, followed by fewer,
but detailed qualitative in-depth interviews (qual) with pa-
tients and providers (i.e., Morse’s QUAN-qual taxonomy)
[18]. The data were integrated in analysis for complemen-
tarity, which seeks “elaboration, enhancement, illustration,
clarification of the results from one method with the results
from the other method” ([19], p259).
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Sampling
Four health sub-districts in different provinces were selected
as sites for this research, two in urban areas (Mitchells Plain
in the Western Cape province and Soweto in Gauteng prov-
ince) and two in rural areas (Bushbuckridge in Limpopo
province and Hlabisa in KwaZulu-Natal province). The
rural–urban selection was designed to capture different
geographic locations; while four different provinces were
selected to allow for insights from different governance
contexts (this is particularly important given the ‘federal’
structure of South Africa, where the provinces have consid-
erable decision-making autonomy). Key officials in the
national and provincial health departments were also
consulted in finalising the selection of sub-districts. User
partners (i.e., senior managers responsible for the services
included in the study) contributed to the final selection of
study sites by identifying sub-districts classified as priority
areas for utilisation and access evaluation. Finally, geo-
graphic access of the investigators to the sub-districts was
also considered.
A two-stage sampling approach was used in each sub-
district, first selecting a representative sample of health facil-
ities, then within these facilities, a representative sample of
users. For ART, all accredited facilities were included where
possible, and where multiple facilities existed, self-weighting
stratified, proportional or probability proportional to size
methods were used to select facilities, again using routine
data on the total number of users in each facility at the time
of the research. Within each chosen facility, a random sam-
ple of patients was interviewed until the proposed facility
sample size was reached. In total, a minimum of 300 pa-
tients were interviewed per sub-district; the planned sample
size was therefore 1200 respondents.
Data collection and capture
Patient exit interview questionnaires were developed to
collect demographic and socio-economic data as well as
information on access to DGs and aspects of access to
health care (Additional file 1). A range of measures of
socio-economic and demographic status were collected,
including employment status, total household consump-
tion expenditure, whether or not the household received
social grants and the value of those grants, and a compos-
ite asset index. The questionnaire was administered by
trained interviewers in the language of the respondent’s
choice. Completed questionnaires were checked for accur-
acy by a data collection coordinator and double entered
into a data entry platform specifically designed for this
purpose in Epidata.
Data analysis
Data were analysed using Stata/IC 11.0. Data were de-
scribed using summary statistics, and logistic regressionswere run to determine the characteristics of respondents
receiving DGs. A composite asset index was created using
multiple correspondence analysis (MCA) on several house-
hold level variables including type of house, material of
walls, type of toilet, primary source of energy for cooking
and ownership of assets such as a vehicle, fridge and live-
stock etc. Given the different governance contexts and
different levels of non-governmental organisation (NGO) in-
volvement between communities, we included dummy vari-
ables for the study sites to explore possible site effects. We
also included variables relating to patient self-reported ad-
herence (ever missed a visit, ever missed medication) and
duration on treatment. We included concomitant treatment
as an explanatory variable in the analysis. Since the pres-
ence of HIV/AIDS increases the risk of TB, there may be
contamination within a particular patient population. For
example, among individuals with TB, those receiving con-
comitant treatment for HIV/AIDS may be more likely to be
receiving the DG because of the support and counselling
provided through ART services. Demographic and socio-
economic variables were entered in the equations as control
variables. The average exchange rate over the period of data
collection was 1 US dollar to 9.03 South African Rands.
Qualitative methods
Sampling
In-depth interviews were conducted with seventeen
ART patients and eighteen ART providers purposively
selected in three of the four sites included in the quanti-
tative phase. The rural site Hlabisa was excluded from
the qualitative phase due to project-related resource
constraints.
Purposive sampling guided the selection of study partici-
pants. The selection criteria for patients included captur-
ing a range of patient treatment experiences, indicated by
patients being classified as either successful and unsuc-
cessful (i.e., with treatment interruptions or treatment
failure); gender; and groups identified through literature
and preliminary data analysis in the quantitative phase as
most likely to be treated differently by providers based
on several factors (e.g., age, nationality, ethnicity, socio-
economic status). To be able to capture the experiences of
both successful and unsuccessful patients required recruit-
ing interviewees beyond the treatment facilities through
other routes including non-governmental organisations
and patient networks. The selection criteria for providers
included staff at different levels of seniority within the fa-
cility, different cadres of staff (professional, administrative
and community treatment supporters) and length of ser-
vice. Interviews were continued until the selection criteria
were met and ‘saturation’ occurred, i.e., until no more
additional themes describing access to care for patients on
ART emerged. Access to DGs was one of these important
themes.
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Semi-structured interview guides were developed for
patients (Additional file 2) and providers. Interviews with
patients explored patient’s life histories (i.e., social support
systems, education, income, migration, work), illness trajec-
tories (i.e., from illness onset to diagnosis and treatment,
treatment seeking, stigma) and experiences with the health
care system (i.e., barriers constraining access and engage-
ments with health care providers). The life and illness histor-
ies, social support narratives and experiences with the health
care system were related as narratives which linked, as the
patient saw it, the role of ART in everyday life [20]. Follow-
up interviews were conducted with patients to clarify uncer-
tainty over timeline and care-seeking events, where neces-
sary. This also provided an opportunity to explore access
issues in greater depth. As a caveat, we did not set out to
investigate the role of DGs specifically at the beginning of
this study; however, these emerged as an important issue
in patients’ narratives that is worthy of further analysis.
Interviews with providers covered a range of topics in-
cluding education and training, career trajectories, family
histories, relationships with patients, colleagues and supervi-
sors. Interviews also allowed for the exploration of con-
straints and challenges providers faced in fulfilling their
roles and their perceptions of the access barriers faced by
patients. Here, complexities around DGs and access to
grants were described.
Data analysis
The transcripts were thematically coded in ATLAS ti.6 by
two members of the research team. Coding was done both
inductively and deductively. It was inductive in that the
two researchers worked independently in reading and re-
reading the transcripts and identified an initial set of
codes, from which emerged several major themes such as
patient and provider expectations. At the same time, the
access-framework provided a conceptual lens from which
hypotheses were derived (e.g., access to the DG alleviates
transport costs and improves affordability, thereby im-
proving adherence) and these hypotheses were tested
against the data. The researchers then compared the simi-
larities and divergences between their codes and themes
to ensure reliability. To ensure rigour, codes and themes
were shared with the wider research team and suggested
modifications were discussed until consensus was reached.
Broader themes which were derived both inductively and
deductively were then related back to the theoretical
framework. Quotations were selected based on their rep-
resentativeness of the emerging themes.
Ethical issues
The Universities of Cape Town, Witwatersrand and Kwa-
Zulu Natal and the South African Provincial Health
Research Committees granted ethical clearance. Informed,written consent to participate in the study was obtained
from each participant. Consent was also obtained to publish
the patient data, subject to the names being anonymised.
Participants were only interviewed if they were over 18 years
of age. In order to ensure patient and provider confidential-
ity, interviews were anonymised and quotations are pre-
sented using pseudonyms and regional location only.Results
Characteristics of recipients of a Disability Grant
Table 1 summarises the demographic, socio-economic and
treatment characteristics of ART patients in our sample ac-
cording to whether they were recipients of a DG or not.
Approximately a third (36.5 %) of all ART patients (n =
1267) received the DG across the four study sites. Un-
employment levels were high among both grant recipients
(90.9 %) and non-recipients (70.1 %). There was no signifi-
cant difference in the demographic characteristics (i.e., age-
sex composition) between grant and non-grant recipients.
Significant differences were found with respect to socio-
economic and treatment characteristics between the two
groups. Grant recipients were comparatively worse off than
non-recipients in terms of socio-economic indicators of
employment (9.1 % vs. 29.9 %) and wealth, measured by the
asset index (58.3 % in the poorest half vs. 45.8 %). With
respect to treatment variables, grant recipients reported
longer treatment duration than non-recipients. Also, a rela-
tively smaller number of grant recipients compared to non-
recipients reported poorer treatment adherence (i.e., missed
clinic visits and missed medication dosages).Predictors of access to the Disability Grant
Table 1 also indicates the adjusted odds ratios (AOR) of re-
ceiving the DG for each demographic, socio-economic and
treatment variable. The data suggest that there was no rela-
tionship (i.e., AOR is either close to or is 1) between grant
receipt and age, sex, asset index, education, and treatment
adherence variables. Unemployment was significantly associ-
ated with receipt of the DG (at the 1 % level). The employed
were significantly less likely to receive the grant than the un-
employed. Significant (at the 5 % level) treatment variables
were treatment duration and those patients receiving con-
comitant treatment for ART or TB (i.e., being treated for
both conditions). We also saw a relationship by site. Patients
in the two urban sites (i.e., Soweto and Mitchells Plain) were
significantly less likely to receive a grant than patients in the
two rural sites (i.e., Bushbuckridge and Hlabisa). However
the likelihood of receiving a grant was not significantly
different between patients in the two rural sites.
In order to understand the role of the DG in enabling
treatment access and sustaining livelihoods and to illu-
minate our quantitative findings further, we analysed the
patient and provider narratives.
Table 1 Characteristics of the recipients of disability grants and determinants of receipt
Variables Category/measure (n = 1267) ART AOR p-value
In receipt of a grant Not in receipt of a grant
(n = 463) (n = 804)
Age Median 39.00 35.00 1.01 0.14
Sex Male 29.37 24.53 1.22 0.19
Female 70.63 75.47 Referent
Employment Employed 9.13 29.89 0.23 0.00
Unemployed 90.87 70.11 Referent
Asset index Wealthier 41.68 54.17 1.10 0.57
Poorer 58.32 45.83 Referent
Education None or some basic 42.64 30.14 Referent
Some secondary 43.29 46.45 0.80 0.18
Completed secondary 14.07 23.41 0.58 0.02
Household expenditure Median 972.22 973.95 1.00 0.05
Site Bushbuckridge 30.67 21.14 Referent
Soweto 16.85 31.47 0.37 0.00
Hlabisa 30.89 19.53 0.96 0.81
Mitchells Plain 21.60 27.86 0.57 0.01
Duration on treatment Median 12.00 10.00 1.01 0.02
Reported missing clinic visit(s) Yes (%) 4.54 5.86 1.10 0.75
Reported missing medication dosage(s) Yes (%) 9.72 16.10 0.81 0.33
Receiving concomitant TB treatment or ART Yes (%) 11.45 9.10 1.68 0.02
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In a context of chronic poverty and high unemployment,
conversations with both patients and providers con-
verged around the centrality of DGs as a lifeline to sur-
vival. Some of the excerpts presented are indicative of
the many ways in which DGs contribute to ameliorating
patients’ everyday challenges that are confounded by the
need to access and adhere to treatment:
It helps me to buy food in the house and take my child
to school. (Patient Tshidiso Mlahleki, Bushbuckridge)
Providers were empathetic about the often desperate
circumstances of patients and understood well their
dependency on the DG:
The majority of our patients come from the township
areas, so we talking sub-economic, we talking like the
basic of the basics…some of them would complain they
don’t have food, so a lot of them are on DGs (Provider
Tasneem Essop, Mitchells Plain)
The role of the DG in enabling patients to pay for
transport fees to the facilities was a recurrent theme
across patients’ and providers’ narratives.I’ve spoken to a lot of my patients…they would not
come for appointments because of money…not having
taxi fare (Provider Michelle May, Mitchells Plain)
In the following quote, the patient referred to her in-
ability to afford the transport costs to the facility once
the DG stopped:
I asked the money from my son, I asked him to give me
R20.00, it is R10.00 a taxi from where I stay to come
here [to the health facility]. … Even this R20.00, I don’t
even know how I am going to pay it back, I don’t
know. I’m not even able to work because I don’t have
the strength. (She started crying) (Patient Silindile
Zama, Bushbuckridge)
In contrast to the above narratives which speak to the
challenges of household survival and being able to access
and follow treatment without the DG, patients receiving
the DG described eloquently the ways in which it en-
abled access to treatment:
I am feeling fine and even my wife she is feeling well…
We are following all the instructions after receiving the
grant. We buy everything that we’re supposed to eat
and we also take our treatment accordingly. And I see
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well and fine… (Patient Glen Mnsinsi, Bushbuckridge)
As noted earlier, once an ART patient’s health im-
proves and their CD4 count rises, they are considered
able to work and they no longer qualify for the DG. In
the absence of the DG, the survival of patients and their
households was tenuous including treatment access:
They cut it [DG] because they say I’m no longer sick, so
now I have to live by borrowing money from people and
paying it back is a challenge because when I do get that
bit of money, the only thing I think about is to buy food
for my kids…(Patient Silindile Zama, Bushbuckridge)
Administrative process for accessing the Disability Grant
Patients and providers also spoke of the administrative chal-
lenges experienced in obtaining the DG. Poor knowledge
and often misconceptions of the grant process and the eligi-
bility criteria were a recurrent theme in both patient and
provider narratives, as evident in the following excerpt:
…they do the height and weight, maybe they see the
weight, and “No, this one can get the grant”, “This one
doesn’t qualify because this one is working, this one is
not working”. The others, their weight is right, so the
doctor says to them “your weight is right, you can go
and find a job, we can’t give you the grant”. (Provider
Thembisile Shaka, Mitchells Plain)
Poor provider knowledge of the DG process and eligi-
bility criteria had implications for how patients under-
stand the process, leading to confusion and mistrust:
Yes, until today, they were refusing saying that they are
looking for a patients whom is unable to do anything…
They are looking for patient who is on the pushcart…You
cannot get any [grant if you are able to walk]…They do
not allow you to see the doctor. I do not know which
procedure are they using to see a doctor; or maybe the
patients are bribing the nurses to see the doctor, because
when I want to see a doctor, they would not allow me and
I would wait until 5 o’clock in the evening and until they
knock off, still queuing to see a doctor. He just came for
couple of hours then he left us behind…hey no, they
[healthcare providers] were undermining me very much..
(Patient Mvelo Moyo, Bushbuckridge)
In contrast, other patients were effectively supported
and guided through the grant process and received their
DG without unnecessary delay:
Oh, to get grant I was told here at the clinic where I
was attending HIV classes…I went to the hall (civic/community hall) where you get application forms…It
was filled the way it was supposed to be filled and I
brought it there when the time was right and it took
two weeks. (Patient Ayabong Dlomo, Mitchells Plain)
The government has attempted to stem the confusion
regarding the eligibility criteria through workshops:
The department tries…once in a year, we get workshops
from them in terms of the criteria that they are using…
so we try and come back and then implement those
changes and then tell our patients that what is now
looked at…you know like the CD4 count thing, they no
longer use it. …They are saying it’s deceiving; they no
longer use it because a patient can have a low CD4
count but they can still be well and able to work…
(Provider Nonkululeko Ntuli, Soweto)
Evident from the foregoing discussion, poor communi-
cation between patients and providers in relation to the
application process and eligibility criteria for the DG had
implications for the nature of the provider-patient rela-
tionship more generally. In some instances patients
viewed providers as cooperative and facilitating access to
the DG and in others providers were viewed with suspi-
cion and as gatekeepers obstructing access to the DG.
Often however, patients perceived providers as being un-
helpful and even discriminatory:
A grant like the people told me about…they say I am
supposed to get one. But the people don’t say anything;
they rather told me I stayed away too many days. I can’t
help if I stay away for many days because I can’t make
it every day. (Patient Mark Kriel, Mitchells Plain)
This suggests that many patients perceived providers
as unhelpful and even impeding their access to the DG.
However, there was also suspicion among some pro-
viders, which influenced their perception and interaction
with patients, often adversely:
Then we get those who want the DG and they feel that if
they finish the treatment, the DG is going to end! So, the
next way to extend the DG is to default. It is not a lot of
those, but you get these serial defaulters, you know they
start getting better, and then they just disappear.
(Provider Dr. Menzi Khumalo, Mitchells Plain)
This contributed to a general sense of helplessness and
disillusionment, often leaving them feeling discouraged
and disempowered, as noted by patients:
When I was applying for a DG, they never wrote full
information on the application form. On top of that,
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not fill the forms in a right way, they do not want to
take your story. For me it meant that I lost the grant,
it has failed. (Patient Malusi Moloi, Soweto)
In summary, the knowledge of the administrative pro-
cesses used to determine eligibility and gain approval and
the administrative process itself appeared to be unnecessar-
ily onerous from the perspective of patients. Besides being
disempowering, patients also suggested that alternative in-
formal criteria were being used by those involved in the ap-
proval process. This was perceived as unfair and a barrier to
accessing the DG which in turn was perceived as a barrier
to accessing ART. At the same time, healthcare providers
themselves expressed uncertainty about the eligibility condi-
tions and process of applying for the DG.
Discussion
This paper focuses on factors that explain variations in
access to the DG, the administrative challenges patients
experience in obtaining the grant and finally the role of
the grant in improving treatment access and sustaining
livelihoods of rural and urban ART patients in SA.
With regard to the first research question (i.e., are there
inequalities in access to the DG for patients on ART?), the
findings do not indicate systematic discrimination between
patients based on socio-economic status or other demo-
graphic variables (i.e., age or sex). However, the quantitative
analyses point to low overall coverage across the four sites
which raises questions of whether there is a problem of tar-
geting and uptake. According to the SASSA guidelines for
2007–08, households with annual income of less than
R58,224 (or R4,852 per month) were eligible for the DG. In
the sampled households, almost all households would be
eligible for the DG, given an average household expenditure
of approximately R972.00 per month. At the same time,
while household income is a necessary criterion for the
DG, the main criteria is proof of disability, which requires
assessment by a clinician appointed for this task.
Importantly, employment was a significant predictor of
access to the DG. Therefore, although the threshold level
of income above which an individual did not qualify for
the DG was relatively high, the probability of a patient fail-
ing to satisfy the means test was expected to be higher
among employed patients than non-employed patients. In
other words, the probability of employed patients receiv-
ing the DG was significantly lower than for unemployed
patients. This might also suggest that the employed found
it more difficult to attend the various stages of the assess-
ment process because of difficulties in arranging time off
work. Alternatively, it might suggest either appropriate
targeting where employment is being used as an informal
assessment either of means or of disability. With respect
to the latter, estimating or verifying a patient’s means maybe difficult and time consuming and so alternative ‘markers’
or proxies (e.g., employment status) may be used by asses-
sors in order to expedite the process (irrespective of the ac-
tual per capita income of the household). However, whether
this was a practice in all or any of the sites cannot be verified
and established from our analysis. But it does imply that
more attention needs to be given to the assessment process.
There are observed inequalities in access across sites,
with higher levels of DG coverage in rural sites. Patients
in the two urban sites are significantly less likely to re-
ceive a grant than patients in Bushbuckridge. A possible
explanation might be that rural patients are more likely
to be unemployed and poorer and therefore more likely
to qualify for grants than those in urban sites. It is also
possible that socio-cultural (e.g., stigma) factors could
play a part in contributing to these observed differences
between the rural and urban sites. Furthermore, in each
sub-district setting, we would expect different imple-
mentation practices given the discretion that implement-
ing actors have regarding service design, including
location, opening hours and referral mechanisms, as well
as the local practices of the doctors that have been
appointed as medical assessors. Finally, our provider in-
terviews indicate that at the facility level, there are differ-
ences in the ways in which specific ART providers
communicate with patients about the grant, and the ex-
tent to which they might go the extra mile to facilitate
access for their patients (see also Elloker et al. [21]).
The interviews with providers and patients point to
the complexity of the DG as a challenge for access. As
Black Sash, an advocacy group has argued “…there has
been no agreed definition of disability or consistent ap-
plication of a standardised tool to assess disability. This
has subjected many of our clients to the discretion of
medical practitioners and officials, which contradicts the
basic principles of administrative justice.” ([22], p3).
Complexity of the grants process and eligibility con-
tributed to delays in access to the grant. As Knight et al.
([12], p143-144) found in their qualitative study of
households in rural KwaZulu-Natal “… the relative tim-
ing of receipt of the disability grant and beginning ART
is important. In contrast to those on ART who received
the grant in good time, those who received it late recov-
ered health more slowly… suggest [ing] that a synergistic
relationship may exist between timeous receipt of this
grant and improved health outcomes on ART.”
The imperfect communication and implementation prac-
tices around the DG and the subsequent misunderstandings
of its processing have impacted relationships and communi-
cation between patients and healthcare providers. This con-
tributed to suspicion and mistrust over the motives of the
other. Providers spoke of patients attempting to defraud the
system. The perception of providers needs to be examined
against the fact that ART patients often show a reduction in
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patients, who are dependent on the DG, tried to avoid a
situation where they were no longer considered disabled
once their health improved. In the absence of employment
opportunities or alternative social assistance mechanisms,
this, as Simchowitz ([23], p12) points out, can create a po-
tentially “vicious cycle of sickness and health,” where discon-
tinuation of the DG might contribute to the health of
patients deteriorating substantially enough to again qualify
for a DG. Similarly, Natrass ([24], p14) speaks of “perverse
incentives”, where patients are left to choose between treat-
ment and health or stronger economic security for them-
selves and their family. On the other hand, patients speak of
being ‘denied’ the grant and of fraudulent and discrimin-
atory practices on the part of the providers. A recent study
exploring the perceptions and experiences regarding the DG
for persons on ART in South Africa concluded that “Partici-
pants valued their health more than the income, however,
and, despite the risk of losing the grant, remained adherent
to ART” [25]
Importantly, patients might view healthcare providers as
fulfilling a role which extends to being gatekeepers of infor-
mation and either facilitators or barriers to accessing the
DG. One might further expect that the nature of the
patient-provider relationship around the DG has implica-
tions for and spills over onto the ART relationship. As previ-
ous research has shown, the social relationship between
patients and providers is crucial for treatment adherence
and success [26]. Further, Noyes and Popay ([27], p238)
argue “misunderstanding and miscommunication between
healthcare professionals and services users appear to be
commonplace.”
This paper provides additional evidence of the role of
the DG in sustaining the livelihoods of often impover-
ished ART patients and also enabling treatment access.
This is consistent with the finding that household ex-
penditure was similar for both grant-recipients and non-
recipients, suggesting that grant recipients could afford
higher expenditure levels owing to the grant. Therefore,
one might presume that the grant ‘fills the gap’ and en-
ables those who receive it to achieve the same levels of
household expenditure as the non-recipients. These
findings are consistent with the findings of previous re-
search on the role of the DG in the context of HIV/
AIDS [28]. Conversely, withdrawal of the DG, once the
health status of the grantee improved impacted adversely
on the lives of patients and their ability to adhere to
treatment (ibid). Even with access to the DG, patients
might employ a variety of other factors to cope with
health care costs, including borrowing money, selling as-
sets and receiving support from family. Fried et al. [15]
use ART patients’ narratives to highlight the challenges
of accessing ART over a long period of time and empha-
sise the importance of social support networks. A relatedpaper [14] provides futher details of these alternative
support methods, and contrasts the experience of ART
patients to the experiences of individuals using TB and
maternity services.
In recent years, there have been increased calls for the
introduction of a Chronic Illness Grant [8, 12, 22, 29, 30].
As argued by Black Sash ([22], p4), “…we do not think it
is appropriate for people who have chronic illnesses to ne-
cessarily be defined as disabled, as it both misrepresents
these people’s potential for health and works perversely
against health-affirming behaviours.” The Chronic Illness
Grant would serve to provide life-long income support for
those with chronic illness including HIV/AIDs and unlike
the DG would not be discontinued once the patient’s
health has improved and the disability has gone. It would
also not prejudice those patients who are employed.
This study has several limitations. Firstly, we did not have
data on patients’ disability. This information would have
allowed us to be able to comment further on patients’ eligi-
bility for the DG. Secondly, at the time of our study, we did
not interview a state-appointed doctor who assesses pa-
tients’ eligibility for the DG. This, given substantial varia-
tions in policy implementation between different provinces,
would have called for a substantial expansion of our data
collection strategy. Thirdly, the rural site Hlabisa was ex-
cluded from the qualitative component of the research.
Therefore, we are unable to identify reasons why patients in
Hlabisa had better access to the DG than those in the other
sites. Fourthly, the cross-sectional design of the quantitative
component does not allow us to comment on the relation-
ship between access to the DG and treatment adherence.
More specifically, we cannot provide evidence based on the
quantitative analysis that DG recipients are more likely to be
adherent (i.e., successful use) than non-recipients. The pa-
tients’ exit interviews do not really explain or illuminate suc-
cessful use very clearly since few people reported low
adherence or missing visits. Further, non-adherent patients
were less likely to be captured in the study, which is a re-
search design issue. Finally, for the qualitative component,
recruitment and follow-up of patients was challenging. In
some instances, although appointments were arranged and
interviewees were reminded about the date of the interview,
they did not meet the appointment. Often cited reasons in-
cluded conflict between appointment and household or
work responsibilities and lack of transport money to the
clinic. Also, tracing patients was complicated by the fact that
many of them did not have a permanent address, or had
provided an incorrect address or were not contactable by
telephone.
Conclusion
A key finding of this paper is that in a context of chronic
unemployment and high levels of poverty, employment is
an important predictor of access to the DG. In addition,
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between patients based on socio-economic status, age or
gender. Further, access to the DG is a life-line for ART
patients. It enables them to meet either fully or partially
the healthcare related costs including transport, food and
other household costs and enables treatment access. In
the case of HIV/AIDS where regular visits to health care
facilities and regular food intake are required, the limited
capacity to borrow money or sell assets may represent a
serious constraint on an individual’s ability to adhere to
recommended treatment plans. Where the treatment is
for infectious conditions–and particularly for those that
carry a high risk of mutation and drug resistance–there is
a clear public interest to provide patients with every op-
portunity to access and adhere to treatment. As argued in
South Africa’s Bill of Rights:
“Everyone has the right to have access to health care
services (…) and social security, including, if they are
unable to support themselves and their dependants,
appropriate social assistance.” (South Africa’s Bill of
Rights) [1].
This quote highlights the progressive constitutional frame-
work governing the country and emphasises post-apartheid
aspirations for a healthy and economically-secure life for all
people in the country. Major restructuring processes and ex-
pansion of both public health care and social security ser-
vices have led to substantial progress in implementing these
fundamental rights. While the DG has clearly played and
continues to play an important role in averting some of the
costs associated with disability arising from HIV/AIDS and
treatment costs, the appropriateness of the grant is ques-
tionable for people living with HIV/AIDS. The introduction
of a Chronic Illness Grant appears to be an appropriate al-
ternative which is likely to encourage treatment adherence
and avert the costs associated with the disease. In addition,
it is imperative for collaborative efforts between the Depart-
ments of Social Development and Health to streamline and
reduce the complexity of the DG application process and in-
form and prepare health care providers who are at the inter-
face between social security and potential recipients. In the
absence of such efforts, poor knowledge of the grants
process and eligibility criteria on the part of patients and
health care providers will continue to lead to poor treatment
access.
Endnotes
1The Social Assistance Act (No. 13 of 2004) defines a
disable person as an adult who is ‘owing to his or her
physical or mental disability, unfit to obtain, by virtue of
any service employment or profession, the means
needed to enable him or her to provide for his or her
maintenance’.2Overall, there are currently seven types of social
grants including not only the Disability Grant but also
Older Persons Grant, Child Support Grant, Care De-
pendency Grant, Foster Child Grant, War Veterans
Grant and the Grant-in-Aid (Department of Social De-
velopment in South Africa 2010).
3People living with HIV/AIDS qualify for and receive a
temporary DG, based on an assessment of the disability
by a state-doctor. The assessment of disability rests with
the doctor who is usually guided by the person’s CD4
count (less than 200) and/or TB/pneumonia related ill-
ness. People with a CD4 count of below 200 will usually
qualify for the DG. At the same time, some people with
CD4 counts of less than 200 may still be assessed as fit
enough to work. Equally some people with CD4 counts
above 200 who are very sick with TB or may qualify for
the grant.
4If the person’s CD4 count increases above 200 with
ART and he/she is judged as fit for work by the doctor,
they will no longer qualify for the DG.
5The study was conducted between 2008 and 2010
6In this study, expenditure is used as proxy for house-
hold incomeAdditional files
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